Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Bruce, Binkowitz"'
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0247059 (2021)
Health insurance and acute hospital-based claims have recently become available as real-world data after marketing in Japan and, thus, classification and prediction using the machine learning approach can be applied to them. However, the methodology
Externí odkaz:
https://doaj.org/article/e808eff5794b4a179feeb3e5fcf67911
Autor:
Josh Chen, Soo Peter Ouyang, William Wang, Paul Gallo, Weining Z. Robieson, Yoko Tanaka, Bruce Binkowitz, Lanju Zhang, Sammy Yuan, Hui Quan, Gang Li, Gordon Lan
Publikováno v:
Simultaneous Global New Drug Development ISBN: 9781003109785
Simultaneous Global New Drug Development
Simultaneous Global New Drug Development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b393b38b957fcf0b7fef84aa9df2572
https://doi.org/10.1201/9781003109785-9
https://doi.org/10.1201/9781003109785-9
Autor:
Mari Ariyasu, Yuko Matsunaga, Matteo Bassetti, Kiichiro Toyoizumi, Tsutae Den Nagata, Bruce Binkowitz, Roger Echols, Yohei Doi
Publikováno v:
Infection and Drug Resistance
Matteo Bassetti,1,2 Mari Ariyasu,3 Bruce Binkowitz,4 Tsutae Den Nagata,3 Roger M Echols,5 Yuko Matsunaga,4 Kiichiro Toyoizumi,4 Yohei Doi6 1Infectious Diseases Clinic, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::083d4ee9a88a4fd95ecde443c2898f1b
https://doi.org/10.2147/idr.s225553
https://doi.org/10.2147/idr.s225553
Autor:
Norman Stockbridge, Bruce Binkowitz, Mouna Akacha, H. M. James Hung, Guenther Mueller-Velten, Brian Claggett
Publikováno v:
Therapeutic Innovation & Regulatory Science. 53:387-397
Serious and chronic health conditions such as cardiovascular diseases (CVDs) are posing challenges to the health system. Recently clinical trials in these fields have focused on composite endpoints that take into account both disease-related mortalit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bc3d7fa4dd213fd4b89378f67e7bda9
https://doi.org/10.1177/2168479018784912
https://doi.org/10.1177/2168479018784912
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 2, p e0247059 (2021)
PLoS ONE, Vol 16, Iss 2, p e0247059 (2021)
Health insurance and acute hospital-based claims have recently become available as real-world data after marketing in Japan and, thus, classification and prediction using the machine learning approach can be applied to them. However, the methodology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::369765bb6ae050da9e52651e701167b6
http://europepmc.org/articles/PMC7886120
http://europepmc.org/articles/PMC7886120
Global simultaneous development is becoming more necessary as the cost of developing medical products continues to grow. The strategy of using multiregional clinical trials (MRCTs) has become the preferred method for developing new medicines. Impleme
Publikováno v:
Wiley StatsRef: Statistics Reference
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45b4d1f13ad969c10ed0ef4e00d2e6e1
https://doi.org/10.1002/9781118445112.stat07977
https://doi.org/10.1002/9781118445112.stat07977
Autor:
Ekopimo Ibia, Michael Rabbia, Sarah Lipsius, Andrew S. Buchanan, Bruce Binkowitz, Yoko Tanaka
Publikováno v:
Therapeutic Innovation & Regulatory Science. 50:91-100
This article describes follow-up work extended from Tanaka et al (2011) in defining the region in multiregional clinical trials (MRCTs). The previous paper advocated a systematic approach to defining regions and recommended the sponsor to think throu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4731ea489f9670b066760bfceb52faed
https://doi.org/10.1177/2168479015604183
https://doi.org/10.1177/2168479015604183
Publikováno v:
Biopharmaceutical Applied Statistics Symposium ISBN: 9789811078286
Drug development has rapidly been globalized, and multi-regional clinical trials (MRCTs) have widely been conducted for the purpose of regulatory filing in multiple regions using the same trial data in inside and outside of ICH (international council
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd7bb6f3691430f0a645ad2e7b0d9c80
https://doi.org/10.1007/978-981-10-7829-3_11
https://doi.org/10.1007/978-981-10-7829-3_11